RESUMEN
The COVID-19 pandemic vaccination infrastructure was redeployed to address the Mpox epidemic. The Westchester County Department of Health coordinated an effective vaccine distribution, tracking, and data collection process with community partners with real-time feedback of operational challenges and updated public health directives. Westchester County, which comprises 9% of the New York State population, administered 24% (6770 doses) of JYNNEOS (smallpox and monkeypox vaccine) across the state. Among first-dose recipients, 13% were Black and 25% were Hispanic, approaching countywide US Census race and ethnicity breakdowns. The operational template designed during COVID-19 can be readily redeployed for subsequent epidemics of even seemingly dissimilar infections like Mpox.
Asunto(s)
COVID-19 , Mpox , Humanos , Pandemias/prevención & control , New York/epidemiología , COVID-19/epidemiología , COVID-19/prevención & control , Brotes de Enfermedades/prevención & controlRESUMEN
In response to a rapid rise in mortality within assisted living, facility-wide resident testing found 42% of 182 residents had SARS-CoV-2 infection; 68% of which were asymptomatic for 14 days before and after testing. Resident testing was a critical infection control measure needed to control transmission of SARS-CoV-2 infection.
Asunto(s)
COVID-19 , SARS-CoV-2 , Infecciones Asintomáticas , Humanos , Control de InfeccionesRESUMEN
The utility of in vitro human disease models is mainly dependent on the availability and functional maturity of tissue-specific cell types. We have previously screened for and identified small molecules that can enhance hepatocyte function in vitro. Here, we characterize the functional effects of one of the hits, FH1, on primary human hepatocytes in vitro, and also in vivo on primary hepatocytes in a zebrafish model. Furthermore, we conducted an analogue screen to establish the structure-activity relationship of FH1. We performed affinity-purification proteomics that identified NQO2 to be a potential binding target for this small molecule, revealing a possible link between inflammatory signaling and hepatocellular function in zebrafish and human hepatocyte model systems.
Asunto(s)
Biomarcadores/metabolismo , Inhibidores Enzimáticos/química , Hepatocitos/metabolismo , Quinona Reductasas/antagonistas & inhibidores , Animales , Inhibidores Enzimáticos/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Humanos , Interleucina-6/genética , Hígado , Simulación del Acoplamiento Molecular , Unión Proteica , Factor de Transcripción STAT3/genética , Transducción de Señal , Relación Estructura-Actividad , Factores de Necrosis Tumoral/genética , Pez CebraRESUMEN
BACKGROUND: Measles was eliminated in the United States through high vaccination coverage and a public health system able to rapidly respond to measles. Measles may occur among vaccinated individuals, but secondary transmission from such individuals has not been documented. METHODS: Suspected patients and contacts exposed during a measles outbreak in New York City in 2011 were investigated. Medical histories and immunization records were obtained. Cases were confirmed by detection of measles-specific immunoglobulin M and/or RNA. Tests for measles immunoglobulin G (IgG), IgG avidity, measurement of measles neutralizing antibody titers, and genotyping were performed to characterize the cases. RESULTS: The index patient had 2 doses of measles-containing vaccine; of 88 contacts, 4 secondary patients were confirmed who had either 2 doses of measles-containing vaccine or a past positive measles IgG antibody. All patients had laboratory confirmation of measles infection, clinical symptoms consistent with measles, and high-avidity IgG antibody characteristic of a secondary immune response. Neutralizing antibody titers of secondary patients reached >80 000 mIU/mL 3-4 days after rash onset and that of the index was <500 mIU/mL 9 days after rash onset. No additional cases of measles occurred among 231 contacts of secondary patients. CONCLUSIONS: This is the first report of measles transmission from a twice-vaccinated individual with documented secondary vaccine failure. The clinical presentation and laboratory data of the index patient were typical of measles in a naive individual. Secondary patients had robust anamnestic antibody responses. No tertiary cases occurred despite numerous contacts. This outbreak underscores the need for thorough epidemiologic and laboratory investigation of suspected cases of measles regardless of vaccination status.
Asunto(s)
Sarampión/transmisión , Vacunación , Adulto , Anciano , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Afinidad de Anticuerpos , Brotes de Enfermedades , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Sarampión/epidemiología , Sarampión/inmunología , Vacuna Antisarampión/administración & dosificación , Vacuna Antisarampión/uso terapéutico , Persona de Mediana Edad , Ciudad de Nueva YorkRESUMEN
In 2003, infection with low pathogenic avian influenza A (H7N2) virus was identified in an immunocompromised man with fever and community-acquired pneumonia in New York, USA. The patient recovered. Although the source of the virus was not identified, this case indicates the usefulness of virus culture for detecting novel influenza A viruses.
Asunto(s)
Anticuerpos Antivirales/sangre , Huésped Inmunocomprometido , Subtipo H7N2 del Virus de la Influenza A/inmunología , Gripe Humana/virología , Animales , Pollos , Infecciones Comunitarias Adquiridas/complicaciones , Humanos , Subtipo H7N2 del Virus de la Influenza A/aislamiento & purificación , Subtipo H7N2 del Virus de la Influenza A/patogenicidad , Gripe Aviar/transmisión , Gripe Aviar/virología , Gripe Humana/diagnóstico , Gripe Humana/inmunología , Masculino , Persona de Mediana Edad , New York , Neumonía/complicaciones , Enfermedades de las Aves de Corral/transmisión , Enfermedades de las Aves de Corral/virología , Cultivo de VirusAsunto(s)
Endometritis/diagnóstico , Tuberculosis de los Genitales Femeninos/diagnóstico , Adulto , Anciano , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , ADN Bacteriano/análisis , Quimioterapia Combinada , Endometritis/tratamiento farmacológico , Endometritis/microbiología , Etnicidad/estadística & datos numéricos , Femenino , Dolor en el Flanco/etiología , Humanos , Recién Nacido , Transmisión Vertical de Enfermedad Infecciosa , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/aislamiento & purificación , Polimorfismo de Longitud del Fragmento de Restricción , Embarazo , Complicaciones Infecciosas del Embarazo/microbiología , Trastornos Puerperales/diagnóstico , Trastornos Puerperales/microbiología , Tuberculoma/diagnóstico , Tuberculoma/tratamiento farmacológico , Tuberculoma/microbiología , Tuberculosis/congénito , Tuberculosis de los Genitales Femeninos/tratamiento farmacológico , Tuberculosis de los Genitales Femeninos/epidemiología , Tuberculosis de los Genitales Femeninos/etnología , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: Despite a decreasing incidence of listeriosis in the United States, molecular subtyping has increased the number of recognized outbreaks. In September 2000, the New York City Department of Health identified a cluster of infections caused by Listeria monocytogenes isolates with identical molecular subtypes by pulsed-field gel electrophoresis (PFGE) and ribotyping. METHODS: To determine the magnitude of the outbreak and identify risk factors for infection, we notified state health departments and conducted a case-control study. A case was defined as a patient or mother-infant pair infected with Listeria monocytogenes whose isolate yielded the outbreak PFGE pattern. Controls were patients infected with Listeria monocytogenes whose isolate yielded a different PFGE pattern. Patients were asked about food and drink consumed during the 30 days before the onset of illness. RESULTS: Between May and December 2000, there were 30 clinical isolates of Listeria monocytogenes with identical PFGE patterns identified in 11 US states. Cases of infection caused by these isolates were associated with 4 deaths and 3 miscarriages. A case-control study implicated sliced processed turkey from a delicatessen (Mantel-Haenszel odds ratio, 8.0; 95% confidence interval, 1.2-43.3). A traceback investigation identified a single processing plant as the likely source of the outbreak, and the company voluntarily recalled 16 million pounds of processed meat. The same plant had been identified in a Listeria contamination event that had occurred more than a decade previously. CONCLUSIONS: Prevention of persistent L. monocytogenes contamination in food processing plants presents a critical challenge to food safety professionals.